In June 2025, Cerapedics secured FDA premarket approval for its PearlMatrix™ P-15 Peptide Enhanced Bone Graft.

In sports medicine, the holy grail for anterior cruciate ligament reconstruction (ACLR) is simple: less pain, faster recovery ...

Orthofix Medical, Inc. reported $203.121 million in sales and ($16,003) million in operating losses for the quarter ending ...

In an industry where everyone talks about “disrupting” spine, Demetra Holding S.p.A. might actually be doing it.

Integra LifeSciences Holdings Corporation reported $415.6 million in sales and ($512.674) million in operating losses for the ...

According to a new meta-analysis in the July 13, 2025, Journal of Experimental Orthopaedics, you’ll need to perform somewhere ...

CONMED’s 2Q25 numbers are in, and the picture is a mix of solid topline growth, orthopedic momentum, and some capital-market ...

It's time to stop casually watching Alphatec Holdings, Inc. and start paying attention—they're not just growing, they’re ...

A new systematic review and meta-analysis in The Journal of Bone and Joint Surgery (July 29, 2025) is asking a question that ...

A worried parent, a stoic (or not-so-stoic) child, and a pediatric back pain story that may or may not rival an epic saga.

In the land of blues, barbecue, and biomedical hustle, Memphis is turning up the volume on medtech innovation.

Sign in by entering the code we sent to , or clicking the magic link in the email.